Intuitive Surgical, Inc. (NASDAQ:ISRG) will release earnings for its first quarter after the closing bell on Tuesday, April 21.

Analysts expect the Sunnyvale, California-based company to report quarterly earnings of $2.11 per share. That’s up from $1.81 per share in the year-ago period. The consensus estimate for Intuitive Surgical's quarterly revenue is $2.62 billion (it reported $2.25 billion last year), according to Benzinga Pro.

On March 18, the U.S. Food and Drug Administration (FDA) issued an early alert highlighting a potentially high-risk issue with stapling devices manufactured by Intuitive Surgical.

Shares of Intuitive Surgical fell 0.8% to close at $465.60 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Truist Securities analyst Richard Newitter maintained a Buy rating and cut the price target from $650 to $580 on April 15, 2026. This analyst has an accuracy rate of 66%.
  • Mizuho analyst Anthony Petrone maintained a Neutral rating and slashed the price target from $575 to $525 on April 13, 2026. This analyst has an accuracy rate of 64%.
  • BTIG analyst Ryan Zimmerman maintained a Buy rating with a price target of $616 on April 10, 2026. This analyst has an accuracy rate of 64%.
  • Evercore ISI Group analyst Vijay Kumar maintained an In-Line rating and lowered the price target from $550 to $480 on April 6, 2026. This analyst has an accuracy rate of 55%.
  • Citigroup analyst Joanne Wuensch upgraded the stock from Neutral to Buy with a price target of $590 on March 11, 2026. This analyst has an accuracy rate of 70%

Considering buying ISRG stock? Here’s what analysts think:

Photo via Shutterstock